Jeanjean L, Lucas X M, Daien V, Chevallier T, Daures J P, De Mattei C, Dupeyron G
Service ophtalmologie, CHU de Nîmes, Nîmes, France; Institut basse vision ARAMAV, Nîmes, France.
Institut basse vision ARAMAV, Nîmes, France.
J Fr Ophtalmol. 2020 Oct;43(8):742-752. doi: 10.1016/j.jfo.2019.10.031. Epub 2020 Jul 8.
To evaluate the ARAMAV 13-30 questionnaire, a new autonomy and quality of life questionnaire developed for visually impaired patients.
We carried out a single-center prospective study at the ARAMAV institute in collaboration with the University Hospital of Nîmes. The patients included were admitted for low vision rehabilitation. Each patient received an occupational therapy assessment, the Short Forms 36 (SF36) quality of life questionnaire and the ARAMAV 13-30 questionnaire at the start and at the end of rehabilitation. We verified the reproducibility, the sensitivity to change, and internal and external consistency of the questionnaire.
We included 231 patients over a period of 4 years. All the patients were blind or visually impaired. We observed excellent intra- and interuser reproducibility of the questionnaire, with a Lin coefficient>0.9 (0.99 and 0.91, respectively). By comparing the variations of the different scores between before and after low vision rehabilitation, we observed excellent sensitivity to change for both the autonomy and quality of life portions of the questionnaire. Finally, we observed excellent internal and external consistency.
We therefore propose the ARAMAV 13-30 questionnaire as a new tool in evaluating autonomy and quality of life specifically in visually impaired patients, which may also be used to assess the effect of low vision rehabilitation.
评估ARAMAV 13 - 30问卷,这是一种为视力受损患者开发的新的自主性和生活质量问卷。
我们与尼姆大学医院合作,在ARAMAV研究所开展了一项单中心前瞻性研究。纳入的患者因低视力康复入院。每位患者在康复开始和结束时均接受职业治疗评估、简短健康调查36项量表(SF36)生活质量问卷以及ARAMAV 13 - 30问卷。我们验证了该问卷的可重复性、对变化的敏感性以及内部和外部一致性。
在4年期间,我们纳入了231名患者。所有患者均为失明或视力受损。我们观察到该问卷在用户内和用户间具有出色的可重复性,林氏系数>0.9(分别为0.99和0.91)。通过比较低视力康复前后不同得分的变化,我们观察到该问卷在自主性和生活质量部分对变化均具有出色的敏感性。最后,我们观察到了出色的内部和外部一致性。
因此,我们建议将ARAMAV 13 - 30问卷作为评估视力受损患者自主性和生活质量的一种新工具,该工具也可用于评估低视力康复的效果。